Sherlock S
Department of Surgery, Royal Free Hospital School of Medicine, London, United Kingdom.
Semin Liver Dis. 1991 Feb;11(1):5-10. doi: 10.1055/s-2008-1040416.
The diagnosis of primary sclerosing cholangitis is made on cholangiographic appearances supported by liver histologic findings. Clinical features may be compatible but are not diagnostic and there is no specific diagnostic test. Immunologic mechanisms have been proposed as pathogenetic, but the evidence is far from conclusive. Similar cholangiographic and histologic changes are found in other diseases of known etiology, including infections with intestinal bacterial organisms and with cryptosporidiosis. Primary sclerosing cholangitis has a strong association with ulcerative colitis and possible mechanisms are discussed. Gut-derived toxic bacterial products may be implicated in the biliary damage. Vascular damage to the hepatic arterial tree by cytotoxic drugs, or after hepatic transplantation, also may produce the picture of sclerosing cholangitis. If the syndrome of sclerosing cholangitis can have so many possible causes, it seems likely that the "primary" type eventually may be found to have a known etiology (possibly infectious). At that point, it will no longer be considered primary.
原发性硬化性胆管炎的诊断基于胆管造影表现,并得到肝脏组织学检查结果的支持。临床特征可能相符,但不具有诊断性,且没有特异性诊断试验。免疫机制被认为是其发病机制,但证据远不确凿。在其他已知病因的疾病中也可发现类似的胆管造影和组织学改变,包括肠道细菌感染和隐孢子虫病。原发性硬化性胆管炎与溃疡性结肠炎密切相关,并对可能的机制进行了讨论。肠道来源的毒性细菌产物可能与胆汁损伤有关。细胞毒性药物或肝移植后对肝动脉树的血管损伤也可能导致硬化性胆管炎的表现。如果硬化性胆管炎综合征有如此多可能的病因,那么“原发性”类型最终可能会被发现有已知病因(可能是感染性)。届时,它将不再被视为原发性。